论文部分内容阅读
1例30岁女性患肝包虫病,术后给予口服甲苯咪唑200mg,2次/d。10d后,患者ALT升高到101U/L,将甲苯咪唑减量至100mg,2次/d。服药20d后,ALT升为200U/L,给予保肝治疗,患者肝功能降至正常范围。继续服用甲苯咪唑,患者ALT升至300U/L,再次停服甲苯咪唑。半月后患者ALT为605U/L,TBil为126μmol/L,并出现纳差、尿黄等症状。给予保肝和对症治疗,25d后患者症状好转,肝功能恢复正常。
A 30-year-old woman with hepatic hydatid disease was given oral mebendazole 200 mg twice daily. After 10 days, patients with ALT increased to 101U / L, mebendazole reduced to 100mg, 2 times / d. After taking medicine 20d, ALT rose to 200U / L, given liver protection, liver function decreased to normal range. Continue to take mebendazole, patients with ALT rose to 300U / L, once again stopped taking mebendazole. Half a month after the patient ALT was 605U / L, TBil was 126μmol / L, and anorexia, urine yellow and other symptoms. Give liver protection and symptomatic treatment, 25 days after the patient’s symptoms improved, liver function returned to normal.